Sie verwenden einen veralteten Browser, welcher von dieser Website nicht unterstützt wird.
Mit dem Benutzen der Webseite erklären Sie sich der Nutzung von Cookies einverstanden. Weitere Pflichtangaben finden Sie in unserer Datenschutzerklärung. Akzeptieren
Zur Startseite Zur Hauptnavigation Zum Inhalt Zum Kontakt Zur Suche Zur Sitemap
+A-
ENDE
  Menü
Institut für Pharmakologie und Toxikologie
  Notfall
  Menü
Startseite / Forschung / Publikationen

Publikationen

2025

  1. Helix-bundle and C-terminal GPCR domains differentially influence GRK-specific functions and ß-arrestin-mediated regulation.  Matthees ESF, Haider RS, Klement L, Reichel M, Blum NK, Weitzel V, Trüpschuch T, Ziegler C, Drube J, Schulz S, Hoffmann C. nature Communication, 16: 5430, 2025

  2. Somatostatin receptor subtypes 1 and 4 regulate neprilysin, the major amyloid-ß degrading enzyme in brain. Nilsson P, Sörgjerd K, Kakiya N, Sasaguri H, Watamura N, Johansson L, Shimozawa M, Tsubuki S, Zhou Z, Lorea-Valencia R, Takamura R, Sekiguchi M, Pegel A, Schulz S, Saito T, Iwata N, Winblad B, Saido TC. J. Alzheimer´s Disease, 1-16, 2025

  3. Unraveling the role of ensheathing cells and perineural fibroblasts in olfactory neurogenesis. Senf K, Nitzsche S, Westermann M, Neuhaus EM. GLIA, 73:2407-2426, 2025

  4. Frolov A, Huang H, Schütz D, Köhne M, Blank-Stein N, Osei-Sarpong C, Büttner M, Elmzzahi T, Khundadze M, Zahid M, Reuter M, Becker M, De Domenico E, Bonaguro L, Kallies A, Morrison H, Hübner CA, Händler K, Stumm R, Mass E, Beyer MD. Microglia and CD8+ T cell activation precede neuronal loss in a murine model of spastic paraplegia 15. J Exp Med. 222(7):e20232357, 2025

  5. CYP1A2 expression and activity in a large panel of human nonneoplastic surgical liver samples: Influence of genetics, lifestyle and other factors. Kuhn UD, Schröter D, Gaßler N, Tautenhahn H-M, Settmacher U, Lupp A: Drug Metabolism and Disposition, 53, 100111, 2025

  6. Koeberle SC, Thürmer M, Su F, Werner M, Grander J, Hofer L, Gollowitzer A, Xuan LL, Benscheid FJ, Bonyadi Rad E, Zarrelli A, Di Fabio G, Werz O, Romanucci V, Lupp A, Koeberle A. Silybin A from Silybum marianum reprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids. Theranostics. 15(5):2006-2034, 2025

  7. Dietz A, Senf K, Neuhaus EM. Stem cell expression of CXCR4 regulates tissue composition in the vomeronasal organ. J Cell Sci. 138(1):jcs263451, 2025

2024

  1. Walker MF, Zhang J, Steiner W, Ku PI, Zhu JF, Michaelson Z, Yen YC, Lee A, Long AB, Casey MJ, Poddar A, Nelson IB, Arveseth CD, Nagel F, Clough R, LaPotin S, Kwan KM, Schulz S, Stewart RA, Tesmer JJG, Caspary T, Subramanian R, Ge X, Myers BR. GRK2 kinases in the primary cilium initiate SMOOTHENED-PKA signaling in the Hedgehog cascade. PLoS Biol. 22(8):e3002685, 2024
  2. Jaeckel ER, Arias-Hervert ER, Perez-Medina AL, Schulz S, Birdsong WT. Chronic Morphine Treatment Induces Sex- and Synapse-Specific Cellular Tolerance on Thalamo-Cortical Mu Opioid Receptor Signaling. J Neurophysiol. 132(3):968-978, 2024
  3. Underwood O, Fritzwanker S, Glenn J, Blum NK, Batista-Gondin A, Drube J, Hoffmann C, Briddon SJ, Schulz S, Canals M. Key phosphorylation sites for robust β-arrestin2 binding at the MOR revisited. Commun Biol. 7(1):933, 2024
  4. Beyer AL, Kaemmerer D, Sänger J, Lupp A. Expression of FAM159B in Humans, Rats, and Mice: A Cross-species Examination. J Histochem Cytochem. 72(7):467-487, 2024
  5. Ruhnke N, Beyer AL, Kaemmerer D, Sänger J, Schulz S, Lupp A. Expression of free fatty acid receptor 2 in normal and neoplastic tissues. Exp Mol Pathol. 137:104902, 2024
  6. Blum NK, Schaffner A, Drube J, Nagel F, Reinscheid RK, Hoffmann C, Schulz S. Rapid elucidation of agonist-driven regulation of the neurokinin 1 receptor using a GPCR phosphorylation immunoassay. Eur J Pharmacol. 973:176587, 2024
  7. Dietz A, Senf K, Neuhaus EM. ACKR3 in olfactory glia cells shapes the immune defense of the olfactory mucosa. Glia. 72(6):1183-1200, 2024
  8. Oteng AB, Pittala S, Kliewer A, Qiu Y, Wess J. Hepatic GRK2 is dispensable for glucose homeostasis and other key metabolic parameters in mice. Mol Metab. 79:101866, 2024
  9. Le VH, Orniacki C, Murcia-Belmonte V, Denti L, Schütz D, Stumm R, Ruhrberg C, Erskine L. CXCL12 promotes the crossing of retinal ganglion cell axons at the optic chiasm. Development 151(2):dev202446, 2024
  10. Jaeckel ER, Herrera YN, Schulz S, Birdsong WT. Chronic morphine induces adaptations in opioid receptor signaling in a thalamo-striatal circuit that are location-dependent, sex-specific and regulated by mu opioid receptor phosphorylation. J Neurosci. 44(3):e0293232023, 2024

2023

  1. Bhat S, Dietz A, Senf K, Nietzsche S, Hirabayashi Y, Westermann M, Neuhaus EM. GPRC5C regulates the composition of cilia in the olfactory system. BMC Biol. 21(1):292, 2023
  2. Leo LM, Al-Zoubi R, Hurst DP, Stephan AP, Zhao P, Tilley DG, Miess E, Schulz S, Abood ME, Reggio PH. The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor. Cannabis Cannabinoid Res. 8(5):731-748, 2023
  3. Kostenis E, Gomeza J, Miess-Tanneberg E, Blum NK, Benkel T, Chevigné A, Hoffmann C, Kolb P, Nikolaev V, Waldhoer M, Szpakowska M, Inoue A, Schulz S. Reply to: How carvedilol does not activate β2-adrenoceptors. Nat Commun. 14(1):7867, 2023
  4. Barki N, Jenkins L, Marsango S, Dedeo D, Bolognini D, Dwomoh L, Abdelmalik AM, Nilsen M, Stoffels M, Nagel F, Schulz S, Tobin AB, Milligan G. Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner. Elife. 12:RP91861, 2023
  5. Oron-Herman M, Kirmayer D, Lupp A, Schulz S, Kostenich G, Afargan M. Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach. Sci Rep. 13(1):20857, 2023
  6. Alexander SP, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Davies JA, Abbracchio MP, Alexander W, Al-Hosaini K, Bäck M, Barnes NM, Bathgate R, Beaulieu JM, Bernstein KE, Bettler B, Birdsall NJM, Blaho V, Boulay F, Bousquet C, Bräuner-Osborne H, Burnstock G, Caló G, Castaño JP, Catt KJ, Ceruti S, Chazot P, Chiang N, Chini B, Chun J, Cianciulli A, Civelli O, Clapp LH, Couture R, Csaba Z, Dahlgren C, Dent G, Singh KD, Douglas SD, Dournaud P, Eguchi S, Escher E, Filardo EJ, Fong T, Fumagalli M, Gainetdinov RR, Gasparo M, Gerard C, Gershengorn M, Gobeil F, Goodfriend TL, Goudet C, Gregory KJ, Gundlach AL, Hamann J, Hanson J, Hauger RL, Hay DL, Heinemann A, Hollenberg MD, Holliday ND, Horiuchi M, Hoyer D, Hunyady L, Husain A, IJzerman AP, Inagami T, Jacobson KA, Jensen RT, Jockers R, Jonnalagadda D, Karnik S, Kaupmann K, Kemp J, Kennedy C, Kihara Y, Kitazawa T, Kozielewicz P, Kreienkamp HJ, Kukkonen JP, Langenhan T, Leach K, Lecca D, Lee JD, Leeman SE, Leprince J, Li XX, Williams TL, Lolait SJ, Lupp A, Macrae R, Maguire J, Mazella J, McArdle CA, Melmed S, Michel MC, Miller LJ, Mitolo V, Mouillac B, Müller CE, Murphy P, Nahon JL, Ngo T, Norel X, Nyimanu D, O'Carroll AM, Offermanns S, Panaro MA, Parmentier M, Pertwee RG, Pin JP, Prossnitz ER, Quinn M, Ramachandran R, Ray M, Reinscheid RK, Rondard P, Rovati GE, Ruzza C, Sanger GJ, Schöneberg T, Schulte G, Schulz S, Segaloff DL, Serhan CN, Stoddart LA, Sugimoto Y, Summers R, Tan VP, Thal D, Thomas WW, Timmermans PBMWM, Tirupula K, Tulipano G, Unal H, Unger T, Valant C, Vanderheyden P, Vaudry D, Vaudry H, Vilardaga JP, Walker CS, Wang JM, Ward DT, Wester HJ, Willars GB, Woodruff TM, Yao C, Ye RD. The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors. Br J Pharmacol. 2023 Oct;180 Suppl 2:S23-S144. doi: 10.1111/bph.16177
  7. Gerlach L, Beyer AL, Kaemmerer D, Sänger J, Evert K, Schulz S, Lupp A. Expression of G protein-coupled receptor GPR19 in normal and neoplastic human tissues. Sci Rep. 13(1):18993, 2023
  8. Modena D, Moras ML, Sandrone G, Stevenazzi A, Vergani B, Dasgupta P, Kliever A, Gulde S, Marangelo A, Schillmaier M, Luque RM, Bäuerle S, Pellegata NS, Schulz S, Steinkühler C. Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas. Cancers (Basel), 15(13):3453, 2023
  9. Dietz A, Senf K, Karius J, Stumm R, Neuhaus EM. Glia Cells Control Olfactory Neurogenesis by Fine-Tuning CXCL12. Cells 12(17):2164, 2023
  10. Requana Aradas A, Djaboub Y, McCort-Tranchepain I, Hajasova Z, Clémenceau L, Canestrelli C, Mann A, Schulz S, Delaval A, Acher F, Massotte D, Noble F, Marie N. Activation of the mu-delta opioid receptor heteromers blocks morphine rewarding effects. Int J Neuropsychopharmacol. 26(7):513-521, 2023
  11. Celik MÖ, Seitz V, Yergöz F, Dembla S, Blum NK, Schulz S, Stein C. Modulation of G-protein activation, calcium currents and opioid receptor phosphorylation by the pH-dependent antinociceptive agonist NFEPP. Front Mol Neurosci. 16:1171855, 2023
  12. Walker MF, Zhang J, Steiner W, Ku PI, Zhu JF, Michaelson Z, Yen YC, Long AB, Casey MJ, Poddar A, Nelson IB, Arveseth CD, Nagel F, Clough R, LaPotin S, Kwan KM, Schulz S, Stewart RA, Tesmer JJG, Caspary T, Subramanian R, Ge X, Myers BR. GRK2 Kinases in the Primary Cilium Initiate SMOOTHENED-PKA Signaling in the Hedgehog Cascade. bioRxiv. 2023 Jul 1:2023.05.10.540226. doi: 10.1101/2023.05.10.540226
  13. Groom S, Blum NK, Conibear AE, Disney A, Hill R, Husbands SM, Li Y, Toll L, Kliewer A, Schulz S, Henderson G, Kelly E, Bailey CP. A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein-coupled receptor kinase. Br J Pharmacol. 180(7):943-957, 2023
  14. Press AT, Ungelenk L, Medyukhina A, Pennington SA, Nietzsche S, Kan C, Lupp A, Dahmen U, Wang R, Settmacher U, Wetzker R, Figge MT, Clemens MG, Bauer M. Sodium thiosulfate refuels the hepatic antioxidant pool reducing ischemia-reperfusion-induced liver injury. Free Radic Biol Med. 204:151-160, 2023
  15. Thompson JM, Tragge W, Flood ED, Schulz S, Lisabeth E, Watts SW. Development of a 5-HT7 receptor antibody for the rat: the good, the bad, and the ugly. Naunyn Schmiedebergs Arch Pharmacol. 396(10):2599-2611, 2023
  16. Fritzwanker S, Nagel F, Kliewer A, Stammer V, Schulz S. In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies. Commun Biol. 6(1):419, 2023
  17. Wende B, Beyer AL, Ruhnke N, Kaemmerer D, Sänger J, Schulz S, Lupp A. Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues. Int J Mol Sci. 24(4):3960, 2023
  18. Wang S, de Fabritus L, Kumar PA, Werner Y, Ma M, Li D, Siret C, Simic M, Li B, Kerdiles YM, Hou L, Stumm R, van de Pavert SA. Brain endothelial CXCL12 attracts protective natural killer cells during ischemic stroke. J Neuroinflammation. 20(1):8, 2023

2022

  1. Albadry M, Höpfl S, Ehteshamzad N, König M, Böttcher M, Neumann J, Lupp A, Dirsch O, Radde N, Christ B, Christ M, Schwen LO, Laue H, Klopfleisch R, Dahmen U. Periportal steatosis in mice affects distinct parameters of pericentral drug metabolism. Sci Rep. 12(1):21825, 2022
  2. Benkel T, Zimmermann M, Zeiner J, Bravo S, Merten N, Lim VJY, Matthees ESF, Drube J, Miess-Tanneberg E, Malan D, Szpakowska M, Monteleone S, Grimes J, Koszegi Z, Lanoiselée Y, O'Brien S, Pavlaki N, Dobberstein N, Inoue A, Nikolaev V, Calebiro D, Chevigné A, Sasse P, Schulz S, Hoffmann C, Kolb P, Waldhoer M, Simon K, Gomeza J, Kostenis E. How Carvedilol activates β2-adrenoceptors. Nat Commun. 13(1):7109, 2022
  3. Siret C, van Lessen M, Bavais J, Jeong HW, Reddy Samawar SK, Kapupara K, Wang S, Simic M, de Fabritus L, Tchoghandjian A, Fallet M, Huang H, Sarrazin S, Sieweke MH, Stumm R, Sorokin L, Adams RH, Schulte-Merker S, Kiefer F, van de Pavert SA. Deciphering the heterogeneity of the Lyve1+ perivascular macrophages in the mouse brain. Nat Commun. 13(1):7366, 2022
  4. Kaufmann J, Blum NK, Nagel F, Schuler A, Drube J, Degenhart C, Engel J, Eickhoff JE, Dasgupta P, Fritzwanker S, Guastadisegni M, Schulte C, Miess-Tanneberg E, Maric HM, Spetea M, Kliewer A, Baumann M, Klebl B, Reinscheid RK, Hoffmann C, Schulz S. A bead-based GPCR phosphorylation immunoassay for high-throughput ligand profiling and GRK inhibitor screening. Commun Biol. 5(1):1206, 2022
  5. Beyer AL, Kaemmerer D, Sänger J, Lupp A. Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study. Int J Mol Sci. 23(21):13503, 2022
  6. Petese A, Fries FL, Broske B, Stumm R, Blaess S: Lineage Analysis of Cxcr4-Expressing Cells in the Developing Midbrain Suggests That Progressive Competence Restriction in Dopaminergic Progenitor Cells Contributes to the Establishment of Dopaminergic Neuronal Diversity. eNeuro. 9(4):ENEURO.0052-22.2022, 2022
  7. Rösner E, Kaemmerer D, Sänger J, Lupp A: Evaluation of PD-L1 expression in a large set of gastroenteropancreatic neuroendocrine tumours and correlation with clinicopathological data. Transl Oncol. 25:101526, 2022
  8. Ehms B, Kaemmerer D, Sänger J, Schulz S, Lupp A: Reassessment of somatostatin receptor SST4 expression in bronchopulmonary and gastroenteropancreatic neuroendocrine neoplasms using the novel rabbit monoclonal anti-human SST4 antibody 7H49L61. Sci Rep. 12(1):14722, 2022
  9. Venkataramanappa S, Saaber F, Abe P, Schütz D, Kumar PA, Stumm R: Cxcr4 and Ackr3 regulate allocation of caudal ganglionic eminence-derived interneurons to superficial cortical layers. Cell Rep. 40(5):111157, 2022
  10. Czajkowski M, Kaemmerer D, Sänger J, Sauter G, Wirtz RM, Schulz S, Lupp A: Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies. BMC Cancer 22(1):740, 2022
  11. Leo LM, Al-Zoubi R, Hurst DP, Stephan AP, Zhao P, Tilley DG, Miess E, Schulz S, Abood ME, Reggio PH: The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor. Cannabis Cannabinoid Res. 2022 Jul 6. doi: 10.1089/can.2021.0223.

  12. Garau C, Liu X, Calo G, Schulz S, Reinscheid RK: Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus. Neuroscience 496:83-95, 2022

  13. Bubb M, Beyer ASL, Dasgupta P, Kaemmerer D, Sänger J, Evert K, Wirtz RM, Schulz S, Lupp A: Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody. Int J Mol Sci. 23:519, 2022

  14. Kotzerke J, Buesser D, Naumann A, Runge R, Huebinger L, Kliewer A, Freudenberg R, Brogsitter C. Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy. Cancers (Basel). 14(10):2513, 2022
  15. Dasgupta P, Mann A, Polgar WE, Reinscheid RK, Zaveri NT, Schulz S: Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics. Sci Rep. 12(1):7154, 2022
  16. Rohlfing AK, Kolb K, Sigle M, Ziegler M, Bild A, Münzer P, Sudmann J, Dicenta V, Harm T, Manke MC, Geue S, Kremser M, Chatterjee M, Liang C, von Eysmondt H, Dandekar T, Heinzmann D, Günter M, von Ungern-Sternberg S, Büttcher M, Castor T, Mencl S, Langhauser F, Sies K, Ashour D, Beker MC, Lämmerhofer M, Autenrieth SE, Schäffer TE, Laufer S, Szklanna P, Maguire P, Heikenwalder M, Müller KAL, Hermann DM, Kilic E, Stumm R, Ramos G, Kleinschnitz C, Borst O, Langer HF, Rath D, Gawaz M: ACKR3 regulates platelet activation and ischemia-reperfusion tissue injury. Nat Commun. 13(1):1823, 2022
  17. Marsango S, Ward RJ, Jenkins L, Butcher AJ, Al Mahmud Z, Dwomoh L, Nagel F, Schulz S, Tikhonova IG, Tobin AB, Milligan G: Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands. J Biol Chem. 298(5):101932, 2022
  18. Beuker C, Schafflick D, Strecker JK, Heming M, Li X, Wolbert J, Schmidt-Pogoda A, Thomas C, Kuhlmann T, Aranda-Pardos I, A-Gonzalez N, Kumar PA, Werner Y, Kilic E, Hermann DM, Wiendl H, Stumm R, Hörste GMZ, Minnerup J: Stroke induces disease-specific myeloid cells in the brain parenchyma and pia.  Nat Commun. 13(1):945, 2022
  19. Divorty N, Jenkins L, Ganguly A, Butcher AJ, Hudson BD, Schulz S, Tobin AB, Nicklin SA, Milligan G: Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor. J Biol Chem. 298(3):101655, 2022
  20. Drube J, Haider RS, Matthees ESF, Reichel M, Zeiner J, Fritzwanker S, Ziegler C, Barz S, Klement L, Filor J, Weitzel V, Kliewer A, Miess-Tanneberg E, Kostenis E, Schulz S, Hoffmann C: GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation. Nat Commun. 13(1):540, 2022

2021

  1. Lupp A, Ehms B, Stumm R, Göckeritz J, Mawrin C, Schulz S: Reassessment of SST4 somatostatin receptor expression using SST4-eGFP knockin mice and the novel rabbit monoclonal anti-human SST4 antibody 7H49L61. Int J Mol Sci. 22(23):12981, 2021
  2. Beyer ASL, Kaemmerer D, Sänger J, Evert K, Lupp, A: Immunohistochemical evaluation of adaptor protein FAM159B expression in normal and neoplastic human tissues. Int J Mol Sci. 22:1225, 2021
  3. Dasgupta P, Gűnther T, Schulz S: Pharmacological characterization of veldoreotide as a somatostatin receptor 4 agonist. Life (Basel) 11(10):1075, 2021
  4. Alexander SP, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Davies JA, Abbracchio MP, Alexander W, Al-Hosaini K, Bäck M, Barnes NM, Bathgate R, Beaulieu JM, Bernstein KE, Bettler B, Birdsall NJM, Blaho V, Boulay F, Bousquet C, Bräuner-Osborne H, Burnstock G, Caló G, Castaño JP, Catt KJ, Ceruti S, Chazot P, Chiang N, Chini B, Chun J, Cianciulli A, Civelli O, Clapp LH, Couture R, Csaba Z, Dahlgren C, Dent G, Singh KD, Douglas SD, Dournaud P, Eguchi S, Escher E, Filardo EJ, Fong T, Fumagalli M, Gainetdinov RR, Gasparo M, Gerard C, Gershengorn M, Gobeil F, Goodfriend TL, Goudet C, Gregory KJ, Gundlach AL, Hamann J, Hanson J, Hauger RL, Hay DL, Heinemann A, Hollenberg MD, Holliday ND, Horiuchi M, Hoyer D, Hunyady L, Husain A, IJzerman AP, Inagami T, Jacobson KA, Jensen RT, Jockers R, Jonnalagadda D, Karnik S, Kaupmann K, Kemp J, Kennedy C, Kihara Y, Kitazawa T, Kozielewicz P, Kreienkamp HJ, Kukkonen JP, Langenhan T, Leach K, Lecca D, Lee JD, Leeman SE, Leprince J, Li XX, Williams TL, Lolait SJ, Lupp A, Macrae R, Maguire J, Mazella J, McArdle CA, Melmed S, Michel MC, Miller LJ, Mitolo V, Mouillac B, Müller CE, Murphy P, Nahon JL, Ngo T, Norel X, Nyimanu D, O'Carroll AM, Offermanns S, Panaro MA, Parmentier M, Pertwee RG, Pin JP, Prossnitz ER, Quinn M, Ramachandran R, Ray M, Reinscheid RK, Rondard P, Rovati GE, Ruzza C, Sanger GJ, Schöneberg T, Schulte G, Schulz S, Segaloff DL, Serhan CN, Stoddart LA, Sugimoto Y, Summers R, Tan VP, Thal D, Thomas WW, Timmermans PBMWM, Tirupula K, Tulipano G, Unal H, Unger T, Valant C, Vanderheyden P, Vaudry D, Vaudry H, Vilardaga JP, Walker CS, Wang JM, Ward DT, Wester HJ, Willars GB, Woodruff TM, Yao C, Ye RD: The concise guide to pharmacology 2021/22: G protein-coupled receptors. Br J Pharmacol. 178 Suppl 1:S27-S156, 2021
  5. Fritzwanker S, Moulédous L, Mollereau C, Froment C, Burlet-Schiltz O, Effah F, Bailey A, Spetea M, Reinscheid RK, Schulz S, Kliewer A: HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants. Commun Biol. 4:1070, 2021
  6. Ridge LA, Kewbank D, Schütz D, Stumm R, Scambler PJ, Ivins S: Dual role for CXCL12 signaling in semilunar valve development. Cell Rep. 36(8):109610, 2021
  7. Fritzwanker S, Schulz S, Kliewer A: SR-17018 stimulates atypical µ-opioid receptor phosphorylation and dephosphorylation. Molecules 26(15):4509, 2021
  8. Gulde S, Wiedemann T, Schillmaier M, Valença I, Lupp A, Steiger K, Yen HY, Bäuerle S, Notni J, Luque R, Schmid H, Schulz S, Ankerst DP, Schilling F, Pellegata NS: Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors. Cancers 13(12):3097, 2021
  9. Si W, Liu X, Pape HC, Reinscheid RK: Neuropeptide S-mediated modulation of prepulse inhibition depends on age, gender, stimulus-timing, and attention. Pharmaceuticals (Basel) 14:489, 2021
  10. Lu JJ, Polgar WE, Mann A, Dasgupta P, Schulz S, Zaveri NT: Differential In vitro pharmacological profiles of structurally diverse nociceptin receptor agonists in activating G-protein and beta-arrestin signaling at the human nociceptin opioid receptor. Mol Pharmacol. 100(1):7-18, 2021
  11. Reinscheid RK, Ruzza C: Pharmacology, physiology and genetics of the neuropeptide S (NPS) system. Pharmaceuticals (Basel) 14:401, 2021
  12. Mann A, Keen AC, Mark H, Dasgupta P, Javitch JA, Canals M, Schulz S, Robert Lane J: New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling. Sci Rep. 11(1):8288, 2021
  13. Garai S, Leo LM, Szczesniak AM, Hurst DP, Schaffer PC, Zagzoog A, Black T, Deschamps JR, Miess E, Schulz S, Janero DR, Straiker A, Pertwee RG, Abood ME, Kelly MEM, Reggio PH, Laprairie RB, Thakur GA: Discovery of a biased allosteric modulator for cannabinoid 1 receptor: Preclinical anti-glaucoma efficacy. J Med Chem. 64(12):8104-8126, 2021
  14. Bertolo A, Nouhoum M, Cazzanelli S, Ferrier J, Mariani JC, Kliewer A, Belliard B, Osmanski BF, Deffieux T, Pezet S, Lenkei Z, Tanter M: Whole-Brain 3D Activation and Functional Connectivity Mapping in Mice using Transcranial Functional Ultrasound Imaging. J Vis Exp. 2021 Feb 24;(168). doi: 10.3791/62267
  15. Venkataramanappa S, Schütz D, Saaber F, Kumar PA, Abe P, Schulz S, Stumm R: The microcephaly gene Donson is essential for progenitors of cortical glutamatergic and GABAergic neurons. PLoS Genet. 17(3):e1009441, 2021
  16. Albanese V, Ruzza C, Marzola E, Bernardi T, Fabbri M, Fantinati A, Trapella C, Reinscheid RK, Ferrari F, Sturaro C, Calo G, Amendola G, Cosconati S, Pacifico S, Guerrini R, Preti D: Structure-activity relationship studies on oxazolo[3,4-a]pyrazine derivatives leading to the discovery of a novel Neuropeptide S receptor antagonist with potent in vivo activity. J Med Chem. 64(7):4089-4108, 2021
  17. Nürge B, Schulz AL, Kaemmerer D, Sänger J, Evert K, Schulz S, Lupp A: Immunohistochemical identification of complementpeptide C5a receptor1 (C5aR1) in non-neoplastic and neoplastic human tissues. PLoS One 16(2):e0246939, 2021
  18. Reinscheid RK, Mafessoni F, Lüttjohann A, Jüngling K, Pape HC, Schulz S: Neandertal introgression and accumulation of hypomorphic mutations in the neuropeptide S (NPS) system promote attenuated functionality. Peptides 138:170506, 2021
  19. Papaioannou NE, Salei N, Rambichler S, Ravi K, Popovic J, Küntzel V, Lehmann CHK, Fiancette R, Salvermoser J, Gajdasik DW, Mettler R, Messerer D, Carrelha J, Ohnmacht C, Haller D, Stumm R, Straub T, Jacobsen SEW, Schulz C, Withers DR, Schotta G, Dudziak D, Schraml BU: Environmental signals rather than layered ontogeny imprint the function of type 2 conventional dendritic cells in young and adult mice. Nat Commun. 12(1):464, 2021
  20. Senf K, Karius J, Stumm R, Neuhaus EM: Chemokine signaling is required for homeostatic and injury-induced neurogenesis in the olfactory epithelium. Stem Cells 39(5):617-635, 2021
  21. Rösner E, Kaemmerer D, Neubauer E, Sänger J, Lupp A: Prognostic value of PD-L1 expression in bronchopulmonary neuroendocrine tumours. Endocr Connect. 10(2):180-190, 2021
  22. Dasgupta P, Günther T, Reinscheid RK, Zaveri NT, Schulz S: Rapid assessment of G protein signaling of four opioid receptors using a real-time fluorescence-based membrane potential assay. Eur J Pharmacol. 890:173640, 2021
  23. Sommerfeld  O, Medyukhina A,  Neugebauer S,  Ghait M,  Ulferts S, Lupp A, König R, Wetzker R, Schulz S, Figge MT,  Bauer M, Press  AT: Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis. Mol Ther. 29(1):338-346, 2021

2020

  1. Simic M, Manosalva I, Spinelli L, Gentek R, Shayan RR, Siret C, Girard-Madoux M, Wang S, de Fabritus L., Verschoor JM, Kerdiles Y, Bahenoff M, Stumm R, Golub R, van de Pavert SA: Distinct Wavews from the Hemogenic endothelium give rise to layered lymphoid tissue inducer cell ontogeny: Cell Rep. 32(6):108004, 2020
  2. Fumagalli A, Heuninck J, Pizzoccaro A, Moutin E, Koenen J, Séveno M, Durroux T, Junier MP, Schlecht-Louf G, Bachelerie F, Schütz D, Stumm R, Smit MJ, Guérineau NC, Chaumont-Dubel S, Marin P: The atypical chemokine receptor 3 interacts with connexin 43 inhibiting astrocytic gap junctional intercellular communication. Nat Commun. 11(1):4855, 2020
  3. Pfeil A, Busch M, Lupp A, Lehmann G, Oelzner P, Wolf G: Innovative rheumatologische und osteologische Medikation im Kontext der chronischen Niereninsuffizienz – Was ist möglich? Akt Rheumatol 45: 173–179, 2020
  4. Werner C, Lupp A, Mtuka-Pardon G, Kloos C, Wolf G, Aschenbach R, Biermann A, Freesmeyer M, Seifert P: Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet. BMC Endocr Disord. 20(1):53, 2020
  5. Werner C, Dirsch O, Dahmen U, Grimm MO, Schulz S, Lupp A: Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies. Transl Oncol. 13(9):100801, 2020
  6. Ydens E, Amann L, Asselbergh B, Scott CL, Martens L, Sichien D, Mossad O, Blank T, De Prijck S, Low D, Masuda T, Saeys Y, Timmerman V, Stumm R, Ginhoux F, Prinz M, Janssens S, Guilliams M: Profiling peripheral nerve macrophages reveals two macrophage subsets with distinct localization, transcriptome and response to injury. Nat Neurosci. 23(5):676-689, 2020
  7. Werner Y, Mass E, Ashok Kumar P, Ulas T, Händler K, Horne A, Klee K, Lupp A, Schütz D, Saaber F, Redecker C, Schultze JL, Geissmann F, Stumm R: CXCR4 distinguishes HSC-derived monocytes from microglia and reveals monocyte immune responses to experimental stroke. Nat Neurosci. 23:351-362, 2020
  8. Mann A, Liebetrau S, Klima M, Dasgupta P, Massotte D, Schulz S: Agonist-induced phosphorylation bar code and differential activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies. Sci Rep. 10(1):8585, 2020
  9. Gillis A, Gondin AB, Kliewer A, Sanchez J, Lim HD, Alamein C, Manandhar P, Santiago M, Fritzwanker S, Schmiedel F, Katte TA, Reekie T, Grimsey NL, Kassiou M, Kellam B, Krasel C, Halls ML, Connor M, Lane JR, Schulz S, Christie MJ, Canals M: Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Sci Signal.  13(625):eaaz3140, 2020
  10. Kliewer A, Gillis A, Hill R, Schmidl F, Baily C, Kelly E, Henderson GJ, Christie MJ, Schulz S: Morphine-induced respiratory depression is independent of ß-arrestin2 signalling. Br J Pharmacol. 177:2923-2931, 2020
  11. Rudeck J, Vogl S, Heinl C, Steinfath M, Fritzwanker S., Kliewer A, Schulz S, Schönfelder G, Bert B: Analgesic treatment with buprenorphine should be adapted to the mouse strain. Pharmacol Biochem Behav. 191:172877, 2020
  12. Gillis A, Kliewer A, Kelly E, Henderson G., Christie MJ, Schulz S, Canals M: Critical assessment of G-protein-biased agonism at the µ-opioid receptor. Trends Pharmacol Sci. 41(12):947-959, 2020
  13. Groom S, Blum NK, Conibear AE, Disney A, Hill R, Husbands SM, Ki Y, Toll L, Kliewer A, Schulz S, Henderson G, Kelly E, Bailey CP: A novel G protein-biased agonist at  the µ opioid receptor induces substantial receptor desensitisation through G protein-coupled receptor kinase. Br J Pharmacol. 2020 Nov 27. doi: 10.1111/bph.15334
  14. Reinscheid RK, Schulz S: Opioid Systems. In: Offermanns S, Rosenthal W. (eds.), Encyclopedia of Molecular Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-030-21573-6_108-1, 2020